Morgan Lewis partner Tom Cartwright discussed the impact of Brexit on the life sciences industry with BioProcess International at the 2019 BIO International Convention. Tom remarked that the sector has already seen reduced investment and regulatory changes with the EMA move from London to Amsterdam and discussed preparations for a “no-deal Brexit.”